ABBV vs AKTX: Valuation Comparison 2026
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from SEC filings.
Side-by-side fundamentals for AbbVie Inc. (ABBV) and Akari Therapeutics Plc (AKTX) — market cap, PE, PEG and sector. All figures from SEC filings and market data.
| Metric | ABBV | AKTX |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Current Price (Cboe, delayed) | $258.15 | $9.01 |
| Market Cap | $456.18B | $1.40T |
| PE Ratio | 72.72 | — |
| PEG Ratio | — | — |
| PEG Verdict | N/A | N/A |